From keeping our nation at the cutting edge to employing millions and supporting countless businesses, America's biopharmaceutical companies help drive the economy through a commitment to innovation.
LATEST ARTICLES
-
Innovation Spotlight: AbbVie Bioresearch Center in Worcester, Mass.
Biopharmaceutical innovation has emerged as a leading area of state economic development. Take Massachusetts, for example.
-
Three Reasons Why Biopharmaceutical Companies Serve as an Engine for Economic Growth
From keeping our nation at the cutting edge to employing millions and supporting countless businesses, America's biopharmaceutical companies are growing the economy through a commitment to innovation.
-
The American Innovation Engine: Keeping the United States Competitive for Biopharmaceutical Investors
Investment is a key driver of innovation across all industries. However, investment is especially important to the research-intensive biopharmaceutical industry.
-
One Out of Every 35 People You Know Has a Job Supported by America's Biopharmaceutical Companies
The biopharmaceutical industry directly employs nearly 803,000 Americans–but that's only part of the story. In fact, the industry supports over 4.7 million U.S. jobs.
RELATED ARTICLES
4 Ways America's Biopharmaceutical Companies are Investing in U.S. Communities
Supporting research and development from America's biopharmaceutical companies means investment in economic growth on a local and national level.
HUBweek 2018: Why Innovation Needs Cross-Sector Collaboration
Innovation does not happen in a vacuum. Instead, it requires a rich ecosystem of talent, capital, expertise and logistics to translate theoretical science into life-saving treatments and therapies.
Our Commitment
We are America's Biopharmaceutical Companies, driven to discover the next lifesaving breakthrough and dedicated to ending the burdens of disease. And with new, innovative medicines on the horizon, we're closer than ever to reaching our goal.
Biopharmaceutical Innovations in Mental Health
Treating patients struggling with mental illness is decidedly one of the most challenging tasks in modern medicine.
Understanding Endometriosis: Current Trends and Future Management
Endometriosis affects an estimated one in 10 women and is associated with debilitating pain symptoms and increased financial burden to patients and the health care system. Dr. Dawn Carlson shares how the biopharmaceutical industry is making an impact on the diagnosis and treatment of a disease that has not seen innovation in decades.
A New Age of Viral Disease Treatment: The Cure Developed by Biopharmaceutical Companies that Saved a Mother of Six
Hepatitis C kills more Americans than any other infectious disease. Carleen was one of those affected. She had five children and was pregnant with her sixth when she was diagnosed with the disease.
